ReviewAmerican journal of cancer research2025

Therapeutic challenges in HER2-targeted antibody therapies: trastuzumab and its ADC derivatives in breast cancer.

Chih-Wei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.